Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/112127
| DC Field | Value | |
|---|---|---|
| dc.title | The prospects for therapy with tumour necrosis factors and their antagonists | |
| dc.contributor.author | Porter, A.G. | |
| dc.date.accessioned | 2014-11-28T02:53:30Z | |
| dc.date.available | 2014-11-28T02:53:30Z | |
| dc.date.issued | 1991 | |
| dc.identifier.citation | Porter, A.G. (1991). The prospects for therapy with tumour necrosis factors and their antagonists. Trends in Biotechnology 9 (1) : 158-162. ScholarBank@NUS Repository. | |
| dc.identifier.issn | 01677799 | |
| dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/112127 | |
| dc.description.abstract | Tumour necrosis factors (TNFs) α and βare capable of causing dramatic necrosis of solid tumours. TNF-α has undergone clinical trends as an anti-cancer drug. Finding a role for TNFs in the treatment of cancer will depend on suppressing severe side effects and targeting the drug. Conversely, due to the participation of TNFs in inflammatory responses, antagonists of TNF-α are being considered for the treatment of several conditions, especially septic shock. | |
| dc.source | Scopus | |
| dc.type | Article | |
| dc.contributor.department | INSTITUTE OF MOLECULAR & CELL BIOLOGY | |
| dc.description.sourcetitle | Trends in Biotechnology | |
| dc.description.volume | 9 | |
| dc.description.issue | 1 | |
| dc.description.page | 158-162 | |
| dc.description.coden | TRBID | |
| dc.identifier.isiut | NOT_IN_WOS | |
| Appears in Collections: | Staff Publications | |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.